Drug recall · April 28, 2021
Betadine recall
Why: Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Betadine (Povidone-Iodine) 5%, 0.5mL per syringe Single Use Syringe Rx only, For Topical Ophthalmic Use (DO NOT INJECT) STERILE OPHTHALMIC SOLUTION, PRESERVATIVE FREE, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178
- Lots / codes
Lot 02-2021-16@4 BUD 5/31/2021
- Quantity
- 5850 syringes
- Company
- Edge Pharma, LLC, Colchester, VT
- Distribution
- Nationwide in the US
- Initiated
- April 12, 2021 · Voluntary: Firm initiated
- Classified
- April 19, 2021
- Reported
- April 28, 2021
- Ended
- February 11, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Povidone-iodine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.